A Win For Co-Diagnostics, Inc.
Thu, Apr 16, 2020 at 05:30 PM
Co-Diagnostics, Inc. (CODX:NASDAQ) rocketted at $13.65, representing a gain of 43.7%. The stock got featured on our News Catalysts scanner on Thu 16 Apr 20 at 07:11 AM in the 'MISCELLANEOUS' category. From Wed 01 Apr 20, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Fri 28 Feb 20 at $21.75 with a volume of 27M+, and its share price has been moving sideways in recent weeks.
About Co-Diagnostics, Inc. (CODX:NASDAQ)
Co-Diagnostics Inc is a molecular diagnostics company that has developed, and intends to sell molecular diagnostic technology such as lab systems and manufacture and sell reagents used for tests.
Top 10 Gainers:
- Taronis Technologies, Inc. (TRNX:NASDAQ), 109.09%
- Arcus Biosciences, Inc. (RCUS:NYSE), 89.35%
- MoSys, Inc. (MOSY:NASDAQ), 87.5%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 61.04%
- Edison Nation, Inc. (EDNT:NASDAQ), 53.89%
- Consumer Portfolio Services, Inc. (CPSS:NASDAQ), 51.92%
- ThermoGenesis Holdings, Inc. (THMO:NASDAQ), 43.79%
- Co-Diagnostics, Inc. (CODX:NASDAQ), 43.68%
- SPI Energy Co., Ltd. (SPI:NASDAQ), 38.71%
- Atossa Therapeutics, Inc. (ATOS:NASDAQ), 37.91%